Akèy › Metiyè › General and Operations Managers › Cambridge, MA
General and Operations Managers nan Cambridge, MA: Salè H-1B
41 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Cambridge, MA. Salè baz medyàn ofri $172,500; mwatye mitan $140,000–$212,972.
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $75,000 |
| Nivo II (kalifye) | $140,000 |
| Nivo III (eksperyans) | $172,500 |
| Nivo IV (plen kompetans) | $274,000 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Amgen Inc. | 3 | $140,000 |
| Massachusetts Institute of Technology | 3 | $400,000 |
| Circe Bioscience, Inc. | 2 | — |
| Vedanta Biosciences, Inc | 2 | $212,212 |
| Biogen Inc. | 2 | $219,720 |
| Everquote, Inc. | 2 | $132,020 |
| North Colony Asset Management, LLC | 2 | $170,000 |
| Microsoft Corporation | 2 | $175,000 |
| KoruLabs LLC | 2 | $71,000 |
| Mepsgenus Inc. | 2 | $138,000 |
| Sanofi US Services Inc. | 1 | $188,178 |
| ModernaTX, Inc. | 1 | $420,000 |
| Gelato USA LLC | 1 | $75,000 |
| Eli Lilly and Company | 1 | $294,170 |
| Integrity Lab Inc. | 1 | $175,000 |
| Ipsen Bioscience, Inc. | 1 | $215,250 |
| CIC Innovation Services, LLC | 1 | $170,000 |
| Ipsen Biopharmaceuticals, Inc. | 1 | $215,250 |
| Wecover Platforms Inc | 1 | $160,160 |
| Ankyra Therapeutics, Inc. | 1 | $274,000 |
| Iterative Scopes, Inc. | 1 | $160,000 |
| ARSA Sustainable Feedstocks LLC | 1 | $116,979 |
| Solvanic, Inc. | 1 | $115,000 |
| Start Hunt LLC | 1 | $70,700 |
| Synthpop Inc. | 1 | $165,000 |
| Prime Bubble Tea LLC | 1 | — |
| AgX Global, Inc | 1 | $90,000 |
| FortyFive Labs Incorporated | 1 | $163,301 |
| AirGarage, Inc | 1 | $190,000 |
Tit travay
- Operations Manager3
- Chief Executive Officer3
- Chief Operating Officer2
- Chief of Staff2
- Senior Director, Global Partnering2
- Business Development Manager2
- Business Management2
- President2
- Director of Strategy and Operations2
- Head, Portfolio Management & Operations1
- VP, Medical Affairs, Latent Viruses1
- Customer Insights Manager1
- Operations Manager 20516.3265.81
- Director, Strategy & Corporate Development (00053995)1
- Sr Director - Medical - Accelerated R&D Leadership Program1
Pwonse H-1B nan Cambridge, MA →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).